DK562686A - 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen - Google Patents

2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen

Info

Publication number
DK562686A
DK562686A DK562686A DK562686A DK562686A DK 562686 A DK562686 A DK 562686A DK 562686 A DK562686 A DK 562686A DK 562686 A DK562686 A DK 562686A DK 562686 A DK562686 A DK 562686A
Authority
DK
Denmark
Prior art keywords
cardiotonics
tautomers
imidazoles
intermediates
preparation
Prior art date
Application number
DK562686A
Other languages
English (en)
Other versions
DK562686D0 (da
Inventor
Donald P Matthews
James R Mccarthy
Jeffrey P Whitten
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK562686D0 publication Critical patent/DK562686D0/da
Publication of DK562686A publication Critical patent/DK562686A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK562686A 1985-11-25 1986-11-24 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen DK562686A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80145885A 1985-11-25 1985-11-25

Publications (2)

Publication Number Publication Date
DK562686D0 DK562686D0 (da) 1986-11-24
DK562686A true DK562686A (da) 1987-05-26

Family

ID=25181154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK562686A DK562686A (da) 1985-11-25 1986-11-24 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen

Country Status (19)

Country Link
EP (1) EP0229922B1 (da)
JP (1) JPS62135461A (da)
KR (1) KR900000671B1 (da)
CN (1) CN86108027A (da)
AT (1) ATE74912T1 (da)
AU (1) AU585409B2 (da)
CA (1) CA1286301C (da)
DE (1) DE3684900D1 (da)
DK (1) DK562686A (da)
ES (1) ES2036520T3 (da)
FI (1) FI864751A (da)
GR (1) GR3004386T3 (da)
HU (1) HU205087B (da)
IL (1) IL80733A0 (da)
NO (1) NO167801C (da)
NZ (1) NZ218354A (da)
PH (1) PH22526A (da)
PT (1) PT83799B (da)
ZA (1) ZA868809B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839375A (en) * 1987-07-28 1989-06-13 Merrell Dow Pharmaceuticals Inc. (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents
US7322704B2 (en) 2004-07-30 2008-01-29 Novalux, Inc. Frequency stabilized vertical extended cavity surface emitting lasers
JP4935090B2 (ja) * 2006-01-31 2012-05-23 ソニー株式会社 半導体発光装置
CN101676293B (zh) * 2008-09-18 2012-11-21 宁波大学 一种联咪唑有机膦化合物及其制备方法
CN102304089A (zh) * 2011-07-01 2012-01-04 中国科学院过程工程研究所 一种4,4′,5,5′-四硝基-2,2′-联咪唑的合成方法

Also Published As

Publication number Publication date
FI864751A0 (fi) 1986-11-21
CA1286301C (en) 1991-07-16
ZA868809B (en) 1987-07-29
ES2036520T3 (es) 1993-06-01
HUT42075A (en) 1987-06-29
PT83799A (en) 1986-12-01
EP0229922A3 (en) 1988-03-30
NZ218354A (en) 1989-09-27
DK562686D0 (da) 1986-11-24
JPS62135461A (ja) 1987-06-18
KR870004977A (ko) 1987-06-02
PH22526A (en) 1988-10-17
ATE74912T1 (de) 1992-05-15
FI864751A (fi) 1987-05-26
HU205087B (en) 1992-03-30
AU585409B2 (en) 1989-06-15
NO167801B (no) 1991-09-02
NO864695D0 (no) 1986-11-24
EP0229922B1 (en) 1992-04-15
GR3004386T3 (da) 1993-03-31
PT83799B (pt) 1988-08-17
EP0229922A2 (en) 1987-07-29
KR900000671B1 (ko) 1990-02-02
IL80733A0 (en) 1987-02-27
CN86108027A (zh) 1987-10-07
AU6556586A (en) 1987-05-28
DE3684900D1 (de) 1992-05-21
NO167801C (no) 1991-12-11

Similar Documents

Publication Publication Date Title
DK470387D0 (da) Heterocycliske forbindelser, fremgangsmaade til dets fremstilling samt deres anvendelse som insecticider
DK504485A (da) Substituerede azolylmethyl-cyclopropyl-carbinol-derivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK266786A (da) 5-amino-1-pyrazoler, deres fremstilling og anvendelse som herbicider, samt ved fremstillingen anvendelige mellemprodukter og fremstillingen deraf
DK144087A (da) 2-azolylmethyl-2-aryl-1,3-dioxolaner, deres fremstilling og anvendelse som antimykotika, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK534286A (da) Nicotinsyrederivater, deres fremstilling og anvendelse som herbicider samt mellemprodukter ved fremstillingen og disses fremstilling
DK143987D0 (da) 2-azolylmethyl-2-aryl-1,3-dioxolaner, deres fremstilling og anvendelse som antimykotika, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK333083A (da) 2-aza-bicyclo(2.2.2)octan-3-carboxylsyrederivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og disses fremstilling
DK578585D0 (da) Aminoacyllabdaner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som laegemidler
DK219685D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK135988D0 (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
DK656588A (da) Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DK170986A (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som famaceutika samt mellem-produkter ved fremstillingen
DK419887D0 (da) Triazolopyrimidin-2-sulfonamider, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse som herbicider
DK123786A (da) 4-(3-carboxy-3-diazo-2-oxopropyl)-azetidin-2-oner, deres fremstilling og anvendelse som carbapenemantibiotikummellemprodukter
NO871051D0 (no) 1,1-disbustituerte cyklopropanderivater, fremgangsmaate til deres fremstilling samt deres anvendelse som antimykotika eller som mellomprodukter.
DK562686A (da) 2,2 -bi-1h-imidazoler, tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som cardiotonika samt mellemprodukter ved fremstillingen
DK393788D0 (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK548486D0 (da) L-arylpyrazoler, deres fremstilling og anvendelse som herbicider
DK687787A (da) Carbamoyloxylabdaner, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter
DK437287A (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
DK183886D0 (da) 4-phenylpropylindolderivater og deres salte og fremgangsmaade til deresfremstilling samt deres anvendelse som laegemidler
NO881775D0 (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaate og mellomprodukter for deres fremstilling samt anvendelse av forbindelsene som medikamenter.
DK167785D0 (da) Substituerede 1-aminoalkylamino-4-aryloxypiperidiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som analgetika
DK10685A (da) Sulfonylguanidinderivater, deres fremstilling og anvendelse som herbicider
DK413485D0 (da) Phenoxypropionsyre-derivater, deres fremstilling og anvendelse som herbicider, samt ved fremstillingen anvendelige mellemprodukter og fremstilling heraf

Legal Events

Date Code Title Description
ATS Application withdrawn